AVA vs EW · P/E 17, rev $1.94B vs P/E 47, rev $1.39B
Avista Corporation (AVA) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Avista Corporation (AVA) is a utilities - diversified company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AVA revenue for 2024-12-31 was $1.94B. Net income was $180.0M. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. AVA currently screens at market cap $3.51B and trailing P/E 16.9.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AVA currently screens at market cap $3.51B and trailing P/E 16.9. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AVA and EW stock pages for the full models.
Not investment advice.